Related Experiment Video
Updated: Apr 11, 2026
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Deciphering the BRCA1 Tumor Suppressor Network
Qinqin Jiang1, Roger A Greenberg1
1Departments of Cancer Biology and Pathology, Abramson Family Cancer Research Institute, and Basser Research Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Abstract:
The BRCA1 tumor suppressor protein is a central constituent of several distinct macromolecular protein complexes that execute homology-directed DNA damage repair and cell cycle checkpoints. Recent years have borne witness to an exciting phase of discovery at the basic molecular level for how this network of DNA repair proteins acts to maintain genome stability and suppress cancer. The clinical dividends of this investment are now being realized with the approval of first-in-class BRCA-targeted therapies for ovarian cancer and identification of molecular events that determine responsiveness to these agents. Further delineation of the basic science underlying BRCA network function holds promise to maximally exploit genome instability for hereditary and sporadic cancer therapy.
Insights
The BRCA1 protein network is crucial for DNA repair and cancer suppression. Understanding its molecular functions is key to developing new BRCA-targeted therapies for ovarian and other cancers.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- The BRCA1 tumor suppressor protein is integral to DNA repair complexes.
- These complexes maintain genome stability and suppress tumor formation.
- Recent discoveries illuminate the molecular mechanisms of this DNA repair network.
Purpose of the Study:
- To review recent advancements in understanding the BRCA1 network's function.
- To highlight the clinical applications of this research in cancer therapy.
- To emphasize the potential for future therapeutic strategies targeting genome instability.
Main Methods:
- Review of recent molecular and genetic studies on BRCA1.
- Analysis of clinical data on BRCA-targeted therapies.
- Synthesis of basic science findings with clinical implications.
Main Results:
- The BRCA1 network plays a vital role in homology-directed DNA repair and cell cycle checkpoints.
- Understanding BRCA1 network function is critical for maintaining genome stability.
- BRCA-targeted therapies are now approved for ovarian cancer, with responsiveness linked to molecular events.
Conclusions:
- Continued basic science research on the BRCA1 network promises to enhance cancer treatment.
- Exploiting genome instability through a deeper understanding of BRCA1 holds therapeutic potential for hereditary and sporadic cancers.
- Further delineation of BRCA network function will maximize its clinical utility in oncology.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions